Tif inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of Tif proteins, which are integral to various cellular processes, including protein synthesis and translational regulation. These inhibitors primarily function by binding to key regions of the Tif proteins, such as their active sites or critical domains that facilitate interactions with ribosomes or other components of the translational machinery. By occupying these essential binding sites, Tif inhibitors effectively block the protein's ability to engage in its normal biological functions, such as initiating or regulating translation. Some Tif inhibitors may also act through allosteric mechanisms, where they bind to sites on the protein that are distinct from the active site, inducing conformational changes that hinder the protein's activity. The effectiveness of these inhibitors is supported by non-covalent interactions, including hydrogen bonds, hydrophobic interactions, van der Waals forces, and ionic bonds, which stabilize the inhibitor-protein complex and ensure effective inhibition.
The structural diversity of Tif inhibitors is critical for their selective interaction with the Tif proteins. These inhibitors often incorporate a variety of functional groups, such as hydroxyl, amine, or carboxyl groups, which facilitate specific interactions with amino acid residues in the protein's binding pockets. Many Tif inhibitors also feature aromatic rings or heterocyclic structures that enhance hydrophobic interactions with non-polar regions of the protein, contributing to the overall stability of the inhibitor-protein complex. The physicochemical properties of Tif inhibitors, including molecular weight, solubility, lipophilicity, and polarity, are meticulously optimized to ensure that they can effectively bind to Tif proteins and remain stable under various biological conditions. By achieving a careful balance of hydrophilic and hydrophobic regions, Tif inhibitors can engage with both polar and non-polar areas of the protein, ensuring robust and efficient inhibition of Tif activity in a range of cellular environments.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, thereby obstructing the transcriptional elongation process, which could lead to a decrease in Tif mRNA synthesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin forms a complex with FKBP12 and binds to mTOR, inhibiting its activity, which is essential for the translation of several proteins including Tif. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide binds to the E site of the 60S ribosomal subunit, arresting translational elongation, which could indirectly reduce Tif protein synthesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine disrupts lysosomal acidification, which could alter cellular signaling and transcriptional pathways leading to a decrease in Tif mRNA production. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide covalently modifies the XPB subunit of TFIIH, hampering RNA polymerase II-mediated transcription, potentially decreasing the synthesis of Tif mRNA. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin specifically inhibits RNA polymerase II, which could reduce the transcription of genes coding for Tif, leading to decreased Tif protein levels. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB selectively inhibits RNA polymerase II by targeting its C-terminal domain phosphorylation, which could lead to a reduction in transcription of Tif mRNA. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide inhibits translation initiation by blocking the assembly of initiation complexes, which could downregulate the synthesis of Tif proteins. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Silvestrol inhibits the helicase activity of eIF4A, necessary for mRNA unwinding, which could decrease the translation of Tif mRNA, reducing Tif protein levels. | ||||||
Harringtonin | 26833-85-2 | sc-204771 sc-204771A sc-204771B sc-204771C sc-204771D | 5 mg 10 mg 25 mg 50 mg 100 mg | $250.00 $367.00 $548.00 $730.00 $980.00 | 30 | |
Harringtonin binds to the 60S ribosomal subunit, preventing the initial elongation step of protein synthesis, which could inhibit the production of Tif. | ||||||